10x Genomics Adds Global Clinical Research Organizations to Expanded Certified Service Provider Network

Q2 Solutions, Azenta Life Sciences, and CellCarta to support large-scale clinical research trials for global pharmaceutical partners PLEASANTON, Calif.  -- 10x Genomics (Nasdaq: TXG), a life sciences leader focused on mastering biology to advance human health, today announced the expansion of its 10x Certified Service Provider (CSP) Network to include three leading clinical research organizations [...]

Inspiring the next generation of researchers

~ STEM education project gives students unique opportunity to experience scientific research ~ A new STEM outreach project saw 2,300 students from 25 schools given the chance to use high-level scientific instruments to carry out their own experiments. Leading manufacturer of scientific equipment, Oxford Instruments, contributed to the project, providing an AZtecLive One Xplore energy [...]

Molecular Devices expands operations in Europe to meet growing demand for 3D biology research

Highlights: Novel 3D biology technology supported by a new €800,000 grant from the Austrian Research Promotion Agency (FFG) Investing to double R&D footprint in Salzburg, Austria Adding customer support roles in Italy, Spain, and Portugal San Jose, C alif.– Molecular Devices, LLC. , a leading provider of high-performance life science solutions, is expanding its R&D facility in [...]

Pluristyx, panCELLa, and Implant Therapeutics Announce a Strategic Alliance to Manufacture and Distribute Genetically Modified, Clinical-grade Human-induced Pluripotent Stem Cells

Improved access to induced pluripotent stem cells for allogeneic cell therapy applications SEATTLE -- Pluristyx, Inc., an advanced therapy tools and services biotechnology company, panCELLa, a privately held biotechnology company, and Implant Therapeutics, a developer of genetically engineered stem cells, today announced they have entered into a manufacturing and distribution strategic alliance that offers cell [...]

Curio Genomics and Daicel Arbor Biosciences Deliver Fully Integrated myCurio™ Bioinformatics Platform

myCurio™ Accelerates Plant Genomics Research & Development ANN ARBOR, MICHIGAN, UNITED STATES -- Curio Genomics and Daicel Arbor Biosciences announced the launch of the cloud-based bioinformatics platform myCurio™, resulting from their multi-year product development and marketing partnership. The integration of myCurio into Arbor's industry-recognized myBaits™ and myReads™ custom NGS products and services provides unique and powerful [...]

PAC’s OptiMVD delivers precise, reliable density and viscosity measurement in a single test run, using only 5 mL of sample

HOUSTON, TX. – PAC LP, a global leader in advanced instrumentation for laboratory and process applications for the oil & gas industry, announces the release of OptiMVD, a unique, compact, benchtop solution that measures viscosity and density very fast, without compromising precision and accuracy. For viscosity, OptiMVD complies with ASTM D7945, a method to measure [...]

Cytiva and Nucleus Biologics join forces to accelerate development of custom cell media for cell and gene therapies

Collaboration will enable transparent, cGMP, and scalable manufacture of custom cell culture media Cytiva, a global life sciences leader, and Nucleus Biologics, LLC, The Cell Performance Company™, have signed a collaboration agreement on custom media formulation and fulfillment solutions for the cell and gene therapy industry. Utilizing Nucleus Biologics’ proprietary platform, Cytiva customers will have [...]

Partnership with RoosterBio to advance scalable & continuous exosomes manufacture

Partnership will optimize manufacturing of extracellular vesicles (EVs) using scalable and continuous bioprocessing technologies to propel the commercialization of regenerative therapies at affordable costs. Proof-of-concept of exosomes manufacturing in scale-X™ bioreactor to demonstrate advantages of intensified and integrated platforms RoosterBio to leverage scalable, continuous bioprocessing technologies to deliver regenerative therapies at reduced timelines and costs, [...]

Cytiva and Nucleus Biologics Join Forces

Cytiva welcomes Nucleus Biologics’ proven and powerful AI-powered interface that brings state-of-the-art cell media design and supply to the Cell and Gene Therapy Industry. Cell and gene therapies are critically reliant on the growth and maintenance of a viable and efficacious cell population. It is proven that cell culture media can have a profound impact [...]

ONI Closes $75 Million Series B Led by ARCH Venture Partners and Casdin Capital

Pioneers in observing single molecules in living cells Funds will be used to build a product portfolio that harnesses the company's innovative technology to unlock new possibilities in therapeutic and diagnostic development as well as basic life science research The company expands its management team and board of directors with the addition of several industry [...]

Access IBO on Knowledge Center